Acelyrin (SLRN) Cash From Operations

Annual CFO

-$169.71 M
-$108.19 M-175.85%

December 31, 2023


Summary


Performance

SLRN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLRNcash flowmetrics:

Quarterly CFO

-$78.76 M
-$32.49 M-70.21%

September 30, 2024


Summary


Performance

SLRN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLRNcash flowmetrics:

TTM CFO

-$255.97 M
-$39.64 M-18.32%

September 30, 2024


Summary


Performance

SLRN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLRNcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SLRN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-175.8%-7.0%-50.8%
3 y3 years-3308.4%-211.0%-254.2%
5 y5 years-3308.4%-211.0%-254.2%

SLRN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3308.4%at low-458.9%at low-1656.6%at low
5 y5-year-3308.4%at low-458.9%at low-1656.6%at low
alltimeall time-3308.4%at low-458.9%at low-1656.6%at low

Acelyrin Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$78.76 M(+70.2%)
-$255.97 M(+18.3%)
Jun 2024
-
-$46.27 M(-19.2%)
-$216.33 M(+7.3%)
Mar 2024
-
-$57.30 M(-22.2%)
-$201.68 M(+18.8%)
Dec 2023
-$169.71 M
-$73.63 M(+88.2%)
-$169.71 M(+48.6%)
Sep 2023
-
-$39.13 M(+23.7%)
-$114.17 M(+27.1%)
Jun 2023
-
-$31.62 M(+24.8%)
-$89.80 M(+24.2%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$25.33 M(+40.0%)
-$72.28 M(+17.5%)
Dec 2022
-$61.52 M(+1135.6%)
-$18.09 M(+22.6%)
-$61.52 M(+41.7%)
Sep 2022
-
-$14.76 M(+4.7%)
-$43.43 M(+51.5%)
Jun 2022
-
-$14.09 M(-3.3%)
-$28.67 M(+96.7%)
Mar 2022
-
-$14.57 M
-$14.57 M
Dec 2021
-$4.98 M
-
-

FAQ

  • What is Acelyrin annual cash flow from operations?
  • What is the all time high annual CFO for Acelyrin?
  • What is Acelyrin annual CFO year-on-year change?
  • What is Acelyrin quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Acelyrin?
  • What is Acelyrin quarterly CFO year-on-year change?
  • What is Acelyrin TTM cash flow from operations?
  • What is the all time high TTM CFO for Acelyrin?
  • What is Acelyrin TTM CFO year-on-year change?

What is Acelyrin annual cash flow from operations?

The current annual CFO of SLRN is -$169.71 M

What is the all time high annual CFO for Acelyrin?

Acelyrin all-time high annual cash flow from operations is -$4.98 M

What is Acelyrin annual CFO year-on-year change?

Over the past year, SLRN annual cash flow from operations has changed by -$108.19 M (-175.85%)

What is Acelyrin quarterly cash flow from operations?

The current quarterly CFO of SLRN is -$78.76 M

What is the all time high quarterly CFO for Acelyrin?

Acelyrin all-time high quarterly cash flow from operations is -$14.09 M

What is Acelyrin quarterly CFO year-on-year change?

Over the past year, SLRN quarterly cash flow from operations has changed by -$5.13 M (-6.97%)

What is Acelyrin TTM cash flow from operations?

The current TTM CFO of SLRN is -$255.97 M

What is the all time high TTM CFO for Acelyrin?

Acelyrin all-time high TTM cash flow from operations is -$14.57 M

What is Acelyrin TTM CFO year-on-year change?

Over the past year, SLRN TTM cash flow from operations has changed by -$86.26 M (-50.83%)